Eleonora Gianti

Flipping in the Pore: Discovery of Dual Inhibitors That Bind in Different Orientations to the Wild-Type versus the Amantadine-Resistant S31N Mutant of the Influenza A Virus M2 Proton Channel

Yibing Wu, Belgin Canturk, Hyunil Jo et al. · Journal of the American Chemical Society · 2014 · 103 citations

Amantadine-resistant S31n Mutant, Molecular Biology, Antiviral Drug +16

Computational analysis of EBNA1 “druggability” suggests novel insights for Epstein-Barr virus inhibitor design

Eleonora Gianti, Troy E. Messick, Paul M. Lieberman et al. · Journal of Computer-Aided Molecular Design · 2016 · 42 citations · Full text

Medicine, Immunology, Computational Analysis +8

Allosteric inhibitors of the main protease of SARS-CoV-2

Subodh Kumar Samrat, Jimin Xu, Xuping Xie et al. · Antiviral Research · 2022 · 41 citations · Full text

Antiviral Drug Development, Allosteric Inhibitors, Antiviral Drug +3

On the role of water density fluctuations in the inhibition of a proton channel

Eleonora Gianti, Lucie Delemotte, Michael L. Klein et al. · Proceedings of the National Academy of Sciences · 2016 · 38 citations · Full text

Biophysical Modeling, Engineering, Nuclear Physics +22

Does Proton Conduction in the Voltage-Gated H⁺ Channel hHv1 Involve Grotthuss-Like Hopping via Acidic Residues?

Siri C. van Keulen, Eleonora Gianti, Vincenzo Carnevale et al. · The Journal of Physical Chemistry B · 2016 · 36 citations · Full text